Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06762795 · ClinicalTrials.gov registry record · NA
The HIEnome Study: Genome Sequencing for Perinatal HIE
A NA study of Hypoxic Ischemic Encephalopathy and Hypoxic Ischemic Encephalopathy (HIE), sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 2
- Study locations
NCT06762795 is a NA study of Hypoxic Ischemic Encephalopathy and Hypoxic Ischemic Encephalopathy (HIE) that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 25 participants, below the 81-participant average among 13 other Hypoxic Ischemic Encephalopathy trials with a reported enrollment target (69% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06762795, a NA study of Hypoxic Ischemic Encephalopathy and Hypoxic Ischemic Encephalopathy (HIE), is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 2
- Study locations
Study Summary
Perinatal hypoxic-ischemic encephalopathy is a rare severe condition in which neonates present with encephalopathy and a clinical history suggestive of prenatal or perinatal hypoxic-ischemic injury. Emerging evidence suggests that genetic conditions are frequently identified in cases of perinatal HIE; however, it is unclear which neonates with this diagnosis warrant genetic testing. This study will offer clinical genome sequencing to neonates with HIE who are undergoing total body cooling (therapeutic hypothermia) and their parents.
Conditions Studied
Interventions
- GENETIC Genome sequencing
Study Locations (2)
Texas
- Texas Children's Hospital - Houston
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-05-15 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06762795
The ClinicalTrials.gov registry entry for NCT06762795 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 81-participant average among 13 other Hypoxic Ischemic Encephalopathy trials with a reported enrollment target (69% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hypoxic Ischemic Encephalopathy appearing as the primary indexed condition, and to 1 intervention - of which Genome sequencing is the first listed.
NCT06762795 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06762795 about?
NCT06762795 is a clinical study titled "The HIEnome Study: Genome Sequencing for Perinatal HIE". Perinatal hypoxic-ischemic encephalopathy is a rare severe condition in which neonates present with encephalopathy and a clinical history suggestive of prenatal or perinatal hypoxic-ischemic injury. Emerging evidence suggests that genetic conditions are frequently identified in cases of perinatal HI...
What is the current status of trial NCT06762795?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-05-15. Estimated completion is 2027-06-30.
What conditions does trial NCT06762795 study?
This clinical trial studies the following conditions: Hypoxic Ischemic Encephalopathy, Hypoxic Ischemic Encephalopathy (HIE), Hypoxic Ischemic Encephalopathy of Newborn.
What interventions are being tested in trial NCT06762795?
The interventions under investigation include: Genome sequencing (GENETIC).
Who is sponsoring clinical trial NCT06762795?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06762795 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxic Ischemic Encephalopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
RECRUITING · NA
-
Spinal Stimulation and Mobility Devices
RECRUITING · NA
-
The Impact of Holding on Stress and Bonding in Mother-Infant Pairs During Therapeutic Hypothermia
COMPLETED · NA
-
Therapeutic Intervention Supporting Development From NICU to 6 Months for Infants Post Hypoxic-Ischemic Encephalopathy
COMPLETED · NA
-
Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia
RECRUITING · Early Phase 1
-
Dose Optimization of Caffeine for HIE
RECRUITING · Phase 1
Explore more on PlainTrial
Hypoxic Ischemic Encephalopathy
All registered trials for this condition
Hypoxic Ischemic Encephalopathy (HIE)
All registered trials for this condition
Texas
All trials with a study site in Texas
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.